Targeting the liver X receptor with dendrogenin A differentiates tumour cells to secrete immunogenic exosome‐enriched vesicles
Open Access
- 11 April 2022
- journal article
- research article
- Published by Wiley in Journal of Extracellular Vesicles
- Vol. 11 (4) , e12211
Abstract
Tumour cells are characterized by having lost their differentiation state. They constitutively secrete small extracellular vesicles (sEV) called exosomes when they come from late endosomes. Dendrogenin A (DDA) is an endogenous tumour suppressor cholesterol‐derived metabolite. It is a new class of ligand of the nuclear Liver X receptors (LXR) which regulate cholesterol homeostasis and immunity. We hypothesized that DDA, which induces tumour cell differentiation, inhibition of tumour growth and immune cell infiltration into tumours, could functionally modify sEV secreted by tumour cells. Here, we have shown that DDA differentiates tumour cells by acting on the LXRβ. This results in an increased production of sEV (DDA‐sEV) which includes exosomes. The DDA‐sEV secreted from DDA‐treated cells were characterized for their content and activity in comparison to sEV secreted from control cells (C‐sEV). DDA‐sEV were enriched, relatively to C‐sEV, in several proteins and lipids such as differentiation antigens, “eat‐me” signals, lipidated LC3 and the endosomal phospholipid bis(monoacylglycero)phosphate, which stimulates dendritic cell maturation and a Th1 T lymphocyte polarization. Moreover, DDA‐sEV inhibited the growth of tumours implanted into immunocompetent mice compared to control conditions. This study reveals a pharmacological control through a nuclear receptor of exosome‐enriched tumour sEV secretion, composition and immune function. Targeting the LXR may be a novel way to reprogram tumour cells and sEV to stimulate immunity against cancer.Keywords
Funding Information
- Institut National Du Cancer (PLBio 12‐130)
- Fondation Toulouse Cancer Santé
This publication has 58 references indexed in Scilit:
- Dendrogenin A arises from cholesterol and histamine metabolism and shows cell differentiation and anti-tumour propertiesNature Communications, 2013
- Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through METNature Medicine, 2012
- Simultaneous Quantification of Cardiolipin, Bis(monoacylglycero)phosphate and their Precursors by Hydrophilic Interaction LC−MS/MS Including Correction of Isotopic OverlapAnalytical Chemistry, 2010
- Exosomes account for vesicle-mediated transcellular transport of activatable phospholipases and prostaglandinsJournal of Lipid Research, 2010
- Rab27a and Rab27b control different steps of the exosome secretion pathwayNature Cell Biology, 2009
- Synthesis of New Alkylaminooxysterols with Potent Cell Differentiating Activities: Identification of Leads for the Treatment of Cancer and Neurodegenerative DiseasesJournal of Medicinal Chemistry, 2009
- Human Tumor-Released Microvesicles Promote the Differentiation of Myeloid Cells with Transforming Growth Factor-β–Mediated Suppressive Activity on T LymphocytesCancer Research, 2006
- Heat Shock Protein 70 Surface-Positive Tumor Exosomes Stimulate Migratory and Cytolytic Activity of Natural Killer CellsCancer Research, 2005
- PLD2 is enriched on exosomes and its activity is correlated to the release of exosomesFEBS Letters, 2004
- Separation and Characterization of Late Endosomal Membrane DomainsJournal of Biological Chemistry, 2002